Skip to main content

Table 1 Inclusion and exclusion criteria

From: Parenteral and oral antibiotic duration for treatment of pediatric osteomyelitis: a systematic review protocol

Inclusion

Exclusion

Randomized Controlled trials

Non- randomized trials

Quasi Randomized Trials

Cohort, case-series or retrospective studies

All languages

Review articles

Acute osteomyelitis

Patients >18 years

Children 0 to 18 years

Chronic or sub-acute osteomyelitis, tuberculosis, sickle cell disease, malignancy, human immunodeficiency virus, chemotherapy

Published or unpublished

Osteomyelitis data cannot be separated from other musculoskeletal/infectious diagnoses

Antibiotic administration with follow-up for 3 months

Intervention other than antibiotic

Identify the anti-microbial and its route

Route of antimicrobial unclear

Identify duration of therapy

Duration of parenteral or enteral therapy unclear

Outcome after 3 months follow-up stated or inferred as clinical cure, failure or relapse

Follow-up not documented